MC2 Therapeutics A/S: Financial statements 2015
CVR: 29526346
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 5,411,435 and a net result of DKK -24,452,032 compared with DKK -19,839,747 the year before. That is a decrease of 3.1% compared with the year before. Equity in the 2015 report amounted to DKK 43,361,966. The solvency ratio was 88.2%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 5,411,435
- Profit/Loss
- DKK -24,452,032
- Equity
- DKK 43,361,966
- Total Assets
- DKK 49,136,472
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 5.4 mio. | -24.5 mio. | 43.4 mio. | 4 |
| 2014 | - | 5.6 mio. | -19.8 mio. | 35.4 mio. | 4 |
| 2013 | - | 3.5 mio. | -25 mio. | 15.9 mio. | 3 |
| 2012 | - | 5.2 mio. | -31.3 mio. | -288.9 mio. | 4 |
Official annual report
How creditworthy is MC2 Therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
MC2 Therapeutics A/S has published its annual report for 2014. Gross profit came to DKK 5,586,065, and the net result was DKK -19,839,747.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.